Skip to Main Content

Author Details

Joe S Mymryk
University of Western Ontario
1989
165
37
PMIDPaper TitleJournal TitlePublished Year
38059331HPV-negative head and neck cancers with adverse pathological features carry specific molecular changes that are associated with survival.Head Neck2024
35317874Establishment of four head and neck squamous cell carcinoma cell lines: importance of reference DNA for accurate genomic characterisation.J Laryngol Otol2023
37949066Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo.Cell Rep Methods2023
37778229Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancer.Oral Oncol2023
37112833The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis.Viruses2023
37370788Differences in the Tumor Microenvironment of EBV-Associated Gastric Cancers Revealed Using Single-Cell Transcriptome Analysis.Cancers (Basel)2023
36680216Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion.Viruses2023
36336610Adenoviruses in medicine: innocuous pathogen, predator, or partner.Trends Mol Med2023
35030304The tumor immune microenvironments of HPV<sup>+</sup> and HPV<sup>-</sup> head and neck cancers.WIREs Mech Dis2022
35343788Prokaryotic Argonaute Protein from Natronobacterium gregoryi Requires RNAs To Activate for DNA Interference <i>In Vivo</i>.mBio2022
36442320Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.EBioMedicine2022
36497170Reduced MHC Class I and II Expression in HPV-Negative vs. HPV-Positive Cervical Cancers.Cells2022
35887988Special Issue "Human Papillomavirus Clinical Research: From Infection to Cancer".J Clin Med2022
36013065HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct.J Clin Med2022
35950764The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human Carcinogenesis.mSphere2022
35227792The Impact of Surgical Resectability on Outcomes for Patients Undergoing Primary Radiation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer.Int J Radiat Oncol Biol Phys2022
35187756Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.Head Neck2022
34066504Metabolic Control by DNA Tumor Virus-Encoded Proteins.Pathogens2021
33824664Does HPV Subtype Predict Outcomes in Head and Neck Cancers?Int J Otolaryngol2021
33588906Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.Infect Agent Cancer2021
33807395Expression and Functional Analysis of the Argonaute Protein of <i>Thermus thermophilus</i> (TtAgo) in <i>E. coli</i> BL21(DE3).Biomolecules2021
33725617All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.Oral Oncol2021
33577808Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies.Antiviral Res2021
34500123Almost famous: Human adenoviruses (and what they have taught us about cancer).Tumour Virus Res2021
347714773p Arm Loss and Survival in Head and Neck Cancer: An Analysis of TCGA Dataset.Cancers (Basel)2021
32146388Sex disparities in head &amp; neck cancer driver genes: An analysis of the TCGA dataset.Oral Oncol2020
31968678Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers.Cancers (Basel)2020
31864959Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer.Oral Oncol2020
31955009A Universal Surrogate Reporter for Efficient Enrichment of CRISPR/Cas9-Mediated Homology-Directed Repair in Mammalian Cells.Mol Ther Nucleic Acids2020
31804024Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition.Mol Oncol2020
32098275High Levels of Class I Major Histocompatibility Complex mRNA Are Present in Epstein-Barr Virus-Associated Gastric Adenocarcinomas.Cells2020
33059733TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma.J Exp Clin Cancer Res2020
33168055Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution.Radiat Oncol2020
33396315Analysis of the TCGA Dataset Reveals that Subsites of Laryngeal Squamous Cell Carcinoma are Molecularly Distinct.Cancers (Basel)2020
32718019Piggybacking on Classical Import and Other Non-Classical Mechanisms of Nuclear Import Appear Highly Prevalent within the Human Proteome.Biology (Basel)2020
32970704Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models.PLoS One2020
32828022Chromosome 3p loss in the progression and prognosis of head and neck cancer.Oral Oncol2020
32901107High MHC-II expression in Epstein-Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation.Sci Rep2020
32641484Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin.J Virol2020
32503156Differential Effects of Human Adenovirus E1A Protein Isoforms on Aerobic Glycolysis in A549 Human Lung Epithelial Cells.Viruses2020
32178827DIY: Visualizing the immune landscape of tumors using transcriptome and methylome data.Methods Enzymol2020
30468243A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth.Int J Cancer2019
31844556Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival.Cancers Head Neck2019
31501315Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.Proc Natl Acad Sci U S A2019
31181773Viral Appropriation: Laying Claim to Host Nuclear Transport Machinery.Cells2019
31394808High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells.Cancers (Basel)2019
31393061Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition.Mol Oncol2019
30744016Metabolic Reprogramming of the Host Cell by Human Adenovirus Infection.Viruses2019
30626742Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.JCI Insight2019
29367252Mimicry of Cellular A Kinase-Anchoring Proteins Is a Conserved and Critical Function of E1A across Various Human Adenovirus Species.J Virol2018
  • 1 - 50 of 165

Recommended Authors

Gladstone Institute of Virology
Career Start Year 2011
Number of shared co-authors 0
Graduate School of Medicine, Kyoto University
Career Start Year 2004
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 0
Princeton University
Career Start Year 2003
Number of shared co-authors 1
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 0
Erasmus University Medical Center
Career Start Year 1999
Number of shared co-authors 0
MRC - University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 1998
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 0
Cancer Research Institute, Central South University
Career Start Year 1995
Number of shared co-authors 0
University of California Berkeley
Career Start Year 1993
Number of shared co-authors 0
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 1
University of California los angeles
Career Start Year 1992
Number of shared co-authors 0
The Children's Hospital of Philadelphia
Career Start Year 1992
Number of shared co-authors 1
National Institute of Child Health & Human Development, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 1
McGill University
Career Start Year 1990
Number of shared co-authors 0
Ontario Institute for Cancer Research, University Avenue
Career Start Year 1990
Number of shared co-authors 2
Cancer Research United Kingdom Manchester Institute, University of Manchester
Career Start Year 1988
Number of shared co-authors 0
Osaka University
Career Start Year 1987
Number of shared co-authors 0
University of British Columbia
Career Start Year 1984
Number of shared co-authors 0
Buck Institute for Research on Aging
Career Start Year 1983
Number of shared co-authors 1
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 3
Frederick National Laboratory for Cancer Research, Inc.
Career Start Year 1980
Number of shared co-authors 0
Tokyo University of Science
Career Start Year 1979
Number of shared co-authors 1
University of California at San Francisco
Career Start Year 1978
Number of shared co-authors 0
University of Washington
Career Start Year 1978
Number of shared co-authors 1
Center for Future Medical Research, Tokyo Medical University
Career Start Year 1975
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 1973
Number of shared co-authors 0
Simons Center for Systems Biology, Institute for Advanced Study
Career Start Year 1967
Number of shared co-authors 0

Collaborators

University of Western Ontario
Co-authored papers 49
University of Western Ontario
Co-authored papers 49
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 33
Schulich School of Medicine & Dentistry, Western University, Victoria Hospital
Co-authored papers 32
University of Western Ontario
Co-authored papers 27
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 25
University of California los angeles
Co-authored papers 20
McMaster Immunology Research Centre, McMaster University
Co-authored papers 19
Western University
Co-authored papers 18
Southern Illinois University School of Medicine
Co-authored papers 14
School of Public Policy at the University of Calgary
Co-authored papers 14
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 12
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 12
Western University
Co-authored papers 11
Western University, Lawson Health Research Institute
Co-authored papers 11
University of Western Ontario
Co-authored papers 10
Moffitt Cancer Center
Co-authored papers 10
Institute of Molecular and Cell Biology, University of Tartu
Co-authored papers 9
Institute of Nuclear Sciences "Vinca"-National Institute of the Republic of Serbia
Co-authored papers 9
Western University
Co-authored papers 9
University of California at Davis School of Medicine
Co-authored papers 8
University of Western Ontario
Co-authored papers 8
University of Western Ontario
Co-authored papers 8
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 7
Western University
Co-authored papers 7
University Health Network
Co-authored papers 7
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 6
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 6
University of Toronto
Co-authored papers 6
Queen's University
Co-authored papers 6